Federico Marchesi1, Roberto Giacosa2, Valeria Reggiani3, Giuseppina De Sario3, Francesco Tartamella3, Elisa Melani3, Maria Teresa Mita3, Francesco Giovanni Cinieri3, Stefano Cecchini3, Matteo Ricco'4, Pierfranco Salcuni5, Luigi Roncoroni3. 1. Dipartimento di Scienze Chirurgiche, sezione di Clinica Chirurgica Generale e Terapia Chirurgica, Università degli studi di Parma, Via Gramsci n.14, 43100, Parma, Italy. fede53@lycos.com. 2. Clinica 'Città di Parma', Dipartimento di Medicina Interna, piazzale Maestri 5, Parma, Italy. 3. Dipartimento di Scienze Chirurgiche, sezione di Clinica Chirurgica Generale e Terapia Chirurgica, Università degli studi di Parma, Via Gramsci n.14, 43100, Parma, Italy. 4. Azienda provinciale per i servizi sanitari della p.a di Trento, UOPSAL. Viale Verona, 38123, Trento, Italy. 5. Dipartimento di Scienze Chirurgiche, sezione di Chirurgia Vascolare, Università degli studi di Parma, Via Gramsci n.14, 43100, Parma, Italy.
Abstract
BACKGROUND: Carotid intima-media thickness (C-IMT) can be considered as an early marker of atherosclerosis, thus representing a reliable cardiovascular risk predictor. Bariatric surgery decreases the burden of cardiovascular disease in obese patients through complex mechanisms, of which weight loss is merely the most evident epiphenomenon. The aim of this study is to evaluate C-IMT variations in patients undergoing Roux-en-Y gastric bypass (RYGB) and possible correlations with biometric parameters and cardiovascular risk factors. METHODS: Thirty patients undergoing RYGB for morbid obesity were enrolled for carotid artery B-mode ultrasound evaluation before surgery and at 1-, 3-, 6-, and 12-month follow-up; C-IMT was recorded at three levels (bulb, common, and internal carotid). At each one of the follow-ups, biometric and serohematic parameters were also collected. RESULTS: The 22 patients who completed the follow-up and were included in the study showed significant C-IMT reduction at all three levels at 12-month follow-up (p < 0.001). Along with a significant BMI reduction and diabetes/hypertension remission, we found a considerable decrease in total cholesterol (219 vs 164 mg/dl; p < 0.001) and uric acid (5.6 vs 4.5 mg/dl; p < 0.01) and a significant increase in HDL cholesterol (43.9vs59.2 mg/dl; p < 0.001). The data imply that the mean 10-year cardiovascular risk score drops by nearly 50 % (5.7 ± 5.6 vs. 2.9 ± 2.7 %, p < 0.001) according to Framingham cardiovascular risk stratification. CONCLUSIONS: RYGB is associated with significant decrease in C-IMT at 1 year. Pathophysiologic processes underlying such a variation, probably involving lipid and urate metabolism and their correlation with cardiovascular risk reduction should be confirmed by long-term prospective trials.
BACKGROUND: Carotid intima-media thickness (C-IMT) can be considered as an early marker of atherosclerosis, thus representing a reliable cardiovascular risk predictor. Bariatric surgery decreases the burden of cardiovascular disease in obesepatients through complex mechanisms, of which weight loss is merely the most evident epiphenomenon. The aim of this study is to evaluate C-IMT variations in patients undergoing Roux-en-Y gastric bypass (RYGB) and possible correlations with biometric parameters and cardiovascular risk factors. METHODS: Thirty patients undergoing RYGB for morbid obesity were enrolled for carotid artery B-mode ultrasound evaluation before surgery and at 1-, 3-, 6-, and 12-month follow-up; C-IMT was recorded at three levels (bulb, common, and internal carotid). At each one of the follow-ups, biometric and serohematic parameters were also collected. RESULTS: The 22 patients who completed the follow-up and were included in the study showed significant C-IMT reduction at all three levels at 12-month follow-up (p < 0.001). Along with a significant BMI reduction and diabetes/hypertension remission, we found a considerable decrease in total cholesterol (219 vs 164 mg/dl; p < 0.001) and uric acid (5.6 vs 4.5 mg/dl; p < 0.01) and a significant increase in HDL cholesterol (43.9vs59.2 mg/dl; p < 0.001). The data imply that the mean 10-year cardiovascular risk score drops by nearly 50 % (5.7 ± 5.6 vs. 2.9 ± 2.7 %, p < 0.001) according to Framingham cardiovascular risk stratification. CONCLUSIONS: RYGB is associated with significant decrease in C-IMT at 1 year. Pathophysiologic processes underlying such a variation, probably involving lipid and urate metabolism and their correlation with cardiovascular risk reduction should be confirmed by long-term prospective trials.
Authors: T Neunteufl; R Katzenschlager; A Hassan; U Klaar; S Schwarzacher; D Glogar; P Bauer; F Weidinger Journal: Atherosclerosis Date: 1997-02-28 Impact factor: 5.162
Authors: David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth Journal: N Engl J Med Date: 2003-06-05 Impact factor: 91.245
Authors: Pilar Cobeta; Alvaro Osorio; Marta Cuadrado-Ayuso; Francisca García-Moreno; David Pestaña; Julio Galindo; José I Botella-Carretero Journal: Obes Surg Date: 2020-03 Impact factor: 4.129
Authors: G Lambert; Marcelo Miranda de Oliveira Lima; A C Felici; J C Pareja; A C J Vasques; F S Novaes; S Rodovalho; F F P Hirsch; J R Matos-Souza; Élinton A Chaim; B Geloneze Journal: Obes Surg Date: 2018-01 Impact factor: 4.129
Authors: Frederik H W Jonker; Vera A A van Houten; Leontine H Wijngaarden; René A Klaassen; André A E A de Smet; André Niezen; Lodewijk J D M Schelfhout; Tobias A Bruning; Erwin van der Harst Journal: Obes Surg Date: 2018-04 Impact factor: 4.129
Authors: Walter J Pories; Terry E Jones; Joseph A Houmard; Eric DeMaria; G Lynis Dohm Journal: Surg Obes Relat Dis Date: 2021-04-09 Impact factor: 3.709
Authors: A S Shah; T Jenkins; Z Gao; S R Daniels; E M Urbina; S Kirk; R Siegel; T H Inge Journal: Int J Obes (Lond) Date: 2017-06-09 Impact factor: 5.095